TABLE 2

Unadjusted and multivariable associations of nasopharyngeal microbiota profiles with bronchiolitis outcomes, MARC-35 cohort

Outcome by microbiota profileUnadjusted modelAdjusted model#
OR (95% CI)p-valueOR (95% CI)p-value
Intensive care use
Haemophilus-dominant profile1.81 (1.07–3.11)0.031.98 (1.08–3.62)0.03
Moraxella-dominant profileReferenceReference
Streptococcus-dominant profile1.46 (0.88–2.45)0.141.32 (0.74–2.34)0.34
 Mixed profile1.28 (0.78–2.16)0.341.19 (0.68–2.09)0.54
Hospital length of stay ≥3 days
Haemophilus-dominant profile2.12 (1.43–3.17)<0.0012.47 (1.60–3.83)<0.001
Moraxella-dominant profileReferenceReference
Streptococcus-dominant profile1.30 (0.90–1.88)0.161.06 (0.71–1.57)0.78
 Mixed profile1.14 (0.80–1.65)0.471.01 (0.68–1.48)0.97
  • Bold results are statistically significant. Full adjusted models are included in supplementary table E3. #: Mixed-effects logistic regression model adjusting for 11 patient-level variables (age, sex, race/ethnicity, gestational age, history of breathing problems, nursey attendance, siblings at home, lifetime history of antibiotic use, history of corticosteroid use, use of antibiotics during the pre-hospitalisation visit and respiratory viruses detected by PCR) and sites as random effect. : Defined as admission to the intensive care unit and/or use of mechanical ventilation (continuous positive airway pressure and/or intubation during inpatient stay, regardless of location) at any time during the index hospitalisation.